Related references
Note: Only part of the references are listed.Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections
Sumio Chono et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2011)
Antimicrobial disposition in pulmonary epithelial lining fluid of horses. Part I. Sulfadiazine and trimethoprim
L. Winther et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2011)
Antimicrobial disposition in pulmonary epithelial lining fluid of horses, Part II. Doxycycline
L. Winther et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2011)
Intrapulmonary Pharmacokinetics of S-013420, a Novel Bicyclolide Antibacterial, in Healthy Japanese Subjects
Hidetoshi Furuie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap!
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2010)
Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections
Kohei Togami et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Antimicrobial chemotherapy and lung microdialysis: a review
Jayesh Dhanani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Permeability and Concentration of Levofloxacin in Epithelial Lining Fluid in Patients With Lower Respiratory Tract Infections
Jing Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pharmacodynamic Profile of Tigecycline against Methicillin-Resistant Staphylococcus aureus in an Experimental Pneumonia Model
Pornpan Koomanachai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole
Keith A. Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions
Eiki Kikuchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid Targets
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA Pneumonia
Yoriko Harigaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3 Lung Epithelial Cell Model
Julien Brillault et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Active Uptake of Ulifloxacin from Plasma to Lung That Controls Its Concentration in Epithelial Lining Fluid
Makoto Aoki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Distribution Characteristics of Telithromycin, a Novel Ketolide Antimicrobial Agent Applied for Treatment of Respiratory Infection, in Lung Epithelial Lining Fluid and Alveolar Macrophages
Kohei Togami et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations
E. De Vecchi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs
Jared L. Crandon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease
Naoki Hasegawa et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains
Somvadee Laohavaleeson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations
Elena De Vecchi et al.
BMC MICROBIOLOGY (2008)
Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects
Sumio Chono et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin
M. Lucchi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid
Eiki Kikuchi et al.
RESPIROLOGY (2008)
Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Tissue concentrations: do we ever learn?
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid
Sungmin Kiem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics
Mark H. Gotfried et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae:: A Monte Carlo simulation analysis
Ayrnan M. Noreddin et al.
CLINICAL THERAPEUTICS (2007)
Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease
John E. Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients
Emmanuel Boselli et al.
INTENSIVE CARE MEDICINE (2007)
Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men
J. Andrews et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America
Andrea M. McCollum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals
G. Suarez-Mier et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin
Adnan Al-Lahham et al.
CHEMOTHERAPY (2007)
Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage
Junko Kikuchi et al.
CLINICAL THERAPEUTICS (2007)
Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections
Sumio Chono et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses
Junko Kikuchi et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals
A. Womble et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2007)
Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia
Emmanuel Boselli et al.
INTENSIVE CARE MEDICINE (2006)
Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals
Ariel Y. Womble et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2006)
Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats
Jin Sun et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae
C. Andrew DeRyke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia
Luis Alou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects
John E. Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum:: an in vitro pharmacodynamic simulation
David Sevillano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia
O Mimoz et al.
INTENSIVE CARE MEDICINE (2006)
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia
MH Scheetz et al.
PHARMACOTHERAPY (2006)
Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations
S Schubert et al.
INFECTION (2005)
Infection site concentrations: Their therapeutic importance and the macrolide and macrolide-like class of antibiotics
GL Drusano
PHARMACOTHERAPY (2005)
Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem
JE Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia
D Panidis et al.
CHEST (2005)
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia
E Boselli et al.
CRITICAL CARE MEDICINE (2005)
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
JE Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery
O Burkhardt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens
TP Lodise et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Lung microdialysis - A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)
M Zeitlinger et al.
AAPS JOURNAL (2005)
Intrapulmonary concentrations of telithromycin: Clinical implications for respiratory tract infections due to Streptococcus pneumoniae
CT Ong et al.
CHEMOTHERAPY (2005)
Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia
E Boselli et al.
CRITICAL CARE MEDICINE (2005)
Pharmacodynamics of moxifloxacin and levofloxacin at simulated epithelial lining fluid drug concentrations against Streptococcus pneumoniae
NR Florea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults
B Capitano et al.
CHEST (2004)
Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials
F Cafini et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations
GG Zhanel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Comparison of 99mTc-DTPA and urea for measuring cefepime concentrations in epithelial fining fluid
S Bayat et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)
AM Noreddin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Differential efficacy of clarithromycin in lung versus thigh infection models
D Maglio et al.
CHEMOTHERAPY (2004)
Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia
E Boselli et al.
INTENSIVE CARE MEDICINE (2004)
Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia
E Boselli et al.
INTENSIVE CARE MEDICINE (2004)
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:: Distribution in tissue
M Müller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects
MH Gotfried et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia
E Boselli et al.
CRITICAL CARE MEDICINE (2003)
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults
KA Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations
GG Zhanel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Intrapulmonary penetration of linezolid
D Honeybourne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects
J Andrews et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid
K Yamazaki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations
AM Noreddin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Intrapulmonary pharmacokinetics of linezolid
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulation
GL Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers
JI Kadota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals
S Jacks et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2001)
Pharmacodynamics of antiinfective therapy: Taking what we know to the patient's bedside
KA Rodvold
PHARMACOTHERAPY (2001)
Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647)
C Muller-Serieys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis
M Rosenfeld et al.
JOURNAL OF PEDIATRICS (2001)
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study
M Cazzola et al.
JOURNAL OF CHEMOTHERAPY (2001)
Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy
D Honeybourne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Lung concentrations of telithromycin after oral dosing
OA Khair et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Seady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects
MH Gotfried et al.
CHEST (2001)
In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics
MB Kays et al.
CLINICAL THERAPEUTICS (2001)
Measurement of the bactericidal activity of fluoroquinolones against Streptococcus pneumoniae using the bactericidal index method
I Morrissey et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients
T Mazzei et al.
JOURNAL OF CHEMOTHERAPY (2000)
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid
B Allegranzi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia
RA Peleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
